Glyxambi Interactions
There are 460 drugs known to interact with Glyxambi (empagliflozin/linagliptin), along with 4 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 2 are major, 457 are moderate, and 1 is minor.
- View all 460 medications that may interact with Glyxambi
- View Glyxambi alcohol/food interactions (2)
- View Glyxambi disease interactions (4)
Most frequently checked interactions
View interaction reports for Glyxambi (empagliflozin / linagliptin) and the medicines listed below.
- amlodipine
- aspirin
- atorvastatin
- carvedilol
- clopidogrel
- Crestor (rosuvastatin)
- cyclobenzaprine
- fenofibrate
- Fish Oil (omega-3 polyunsaturated fatty acids)
- furosemide
- gabapentin
- glimepiride
- glipizide
- hydrochlorothiazide
- Jardiance (empagliflozin)
- levothyroxine
- lisinopril
- losartan
- metformin
- metoprolol
- Metoprolol Tartrate (metoprolol)
- omeprazole
- pantoprazole
- rosuvastatin
- simvastatin
- tamsulosin
- Trulicity (dulaglutide)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Glyxambi alcohol/food interactions
There are 2 alcohol/food interactions with Glyxambi (empagliflozin / linagliptin).
Glyxambi disease interactions
There are 4 disease interactions with Glyxambi (empagliflozin / linagliptin) which include:
More about Glyxambi (empagliflozin / linagliptin)
- Glyxambi consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (22)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antidiabetic combinations
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.